uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted September 19, 2018

FDA Warns Seller of Shilajit

On September 6, 2018, the FDA issued a warning letter to Adaptive Energy LLC, following an inspection of the company's website, which found statements made about its shilajit product, Purblack were found to be drug claims.

For example, Purblack was promoted with statements such as "Unique resins like Purblack, aid in fighting numerous addictions; not just to opioids, but cannabis and pain pills, as well," and "There's a reason that eastern medicine has been prescribing shilajit for centuries to stop addictions."

In addition, the product was found to be misbranded because its label fails to bear adequate directions for its intended use, as required by federal regulations.

For more information about shilajit, see's answer to the question: What is shilajit? Does it have any proven benefits, and is heavy metal contamination a concern?

See Related Warnings:

FDA Warns Seller of Joint Health and Cholesterol Supplements

Seller of Apple Cider Vinegar, Joint Supplements & More Warned for Drug Claims

FDA Warns Seller of Milk Thistle, Chromium, Joint Supplements & More for Manufacturing Violations

Seller of Male Enhancement, Prostate Supplements & More Warned for Drug Claims

FDA Warns Seller of Arthritis, Blood Pressure, Diabetes Supplements For Making Drug Claims

FDA Warns Seller of Supplements for Allergies, Joint Pain, Bone Health, and More

To read the full warning letter, use the link below: